Contact Us

Phone
Alison Hey-Cunningham +61 2 9515 6651    

Email
alison.hey-cunningham@sydney.edu.au

Address
Centre of Research Excellence in Pulmonary Fibrosis
Respiratory Medicine and Sleep Unit
Level 11, Royal Prince Alfred Hospital
Camperdown NSW 2050

Facebook

Twitter

Online Enquiry

* Required fields

Resources for Healthcare Professionals

 

Interstitial Lung Disease MDM Toolkit

The interstitial lung disease MDM toolkit has been developed By A/Prof Ian Glaspole and Prof Anne Holland in collaboration with the Lung Foundation Australia. The toolkit contains resources designed to aid in the presentation and discussion of cases presented at ILD multidisciplinary meetings.

The toolkit is available here.

 

TSANZ/LFA Diagnosis and Treatment Position Papers

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia:

http://onlinelibrary.wiley.com/doi/10.1111/resp.13146/full

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia:

http://onlinelibrary.wiley.com/doi/10.1111/resp.13163/full

Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand:

http://onlinelibrary.wiley.com/doi/10.1111/resp.13977

 

PACT-TSANZ Webinars

This collaborative webinar series educates and upskills health professionals on topics relating to pulmonary fibrosis clinical research. Topics available to watch on demand include:

  • Accelerating translational research to find a cure for IPF: Can we REMAP-ILD?

This webinar educated health professionals about a Randomised, Embedded, Multifactorial, Adaptive, Platform (REMAP) trial design for interstitial lung disease (ILD). Presented by Prof Gisli Jenkins. Click here to view the recording.

  • Pragmatic trials and registry/EMR-based studies

This webinar educated health professionals about pragmatic clinical trials and registry/electronic medical record-based studies. Presented by Prof David Price. Click here to view the recording.

  • ATS 2022 pulmonary fibrosis in a nutshell - What's the latest in PF clinical research?

This webinar caught health professionals up on the latest in clinical research in pulmonary fibrosis from the May 2022 ATS conference. Presented by A/Prof Yet Khor. Click here to view the recording.

  • Planning for implementation using science and strategy

This webinar educated health professionals about the science and strategy of implementation in the context of clinical trials, including insights on planning for future implementation. Presented by Prof Natasha Lannin. Click here to review the recording. 

    • ATS recap - What's the latest in pulmonary fibrosis clinical research?

    This webinar caught health professionals up on the latest in clinical research in pulmonary fibrosis from the May 2021 ATS conference. Presented by A/Prof Ian Glaspole. Click here to view the recording.

    • New drugs for pulmonary fibrosis - are there any blockbusters around the corner?

    This webinar caught health professionals up on the latest in drug development and clinical trials in pulmonary fibrosis. Presented by Prof Glen Westall and Prof Dan Chambers. Click here to view the recording.

     

    Pulmonary Fibrosis Australasian Clinical Trials Network’ - PACT

    For more information, please go to the PACT website.

     

    ‘Australasian Interstitial Lung Disease Registry’ - AILDR

    For more information, please go to the AILDR website.

     

    ‘Thank you for asking’: Addressing consumer priorities in respiratory medicine research

    This public lecture was presented on October 29, 2021 by Prof Anne Holland, Professor of Physiotherapy and Head of Respiratory Research at Alfred Health and Monash University’s Central Clinical School. Prof Holland outlined the ways in which consumer experiences (good and bad) have prompted development of new interventions, given rise to clinical trials and changed clinical practice, and highlighted new opportunities to address the research priorities of people living with chronic lung disease. To see the recording on YouTube click here.